Universal Health Services (UHS)

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCEMay 27, 2026 4:15 PM
PR Newswire (US) KING OF PRUSSIA, Pa., May 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the Goldman Sachs Annual Global Healthcare Conference on June 9, 2026, at 8:00am ET.A live audio webcast of the presentation and a webcast replay will be available at the Investor Relations section of the Company's website (www.uhsinc.com).Universal Health Services, Inc. is one of the nation's largest and most respected providers of hospital and healthcare services, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico.   View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-to-present-at-goldman-sachs-annual-global-healthcare-conference-302782973.htmlSOURCE Universal Health Services, Inc. Original: UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL HEALTHCARE CONFERENCE

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDENDMay 27, 2026 4:10 PM
PR Newswire (US) KING OF PRUSSIA, Pa., May 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on June 18, 2026 to shareholders of record as of June 8, 2026.Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom. View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-dividend-302783476.htmlSOURCE Universal Health Services, Inc. Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT BOFA SECURITIES HEALTH CARE CONFERENCEApril 30, 2026 4:15 PM
PR Newswire (US)

KING OF PRUSSIA, Pa., April 30, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the BofA Securities Health Care Conference on May 12, 2026, at 1:40pm PT.







A live audio webcast of the presentation and a webcast replay will be available at the Investor Relations section of the Company's website (www.uhsinc.com).Universal Health Services, Inc. is one of the nation's largest and most respected providers of hospital and healthcare services, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico. 



View original content to download multimedia:https://www.prnewswire.com/news-releases/universal-health-services-inc-to-present-at-bofa-securities-health-care-conference-302759375.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT BOFA SECURITIES HEALTH CARE CONFERENCE

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026April 27, 2026 4:15 PM
PR Newswire (US)

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended March 31, 2026 and 2025:KING OF PRUSSIA, Pa., April 27, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $348.7 million, or $5.65 per diluted share, during the first quarter of 2026, as compared to $316.7 million, or $4.80 per diluted share, during the first quarter of 2025.  Net revenues increased by 9.6% to $4.495 billion during the first quarter of 2026, as compared to $4.100 billion during the first quarter of 2025.As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our adjusted net income during the first quarter of 2026 was $346.5 million, or $5.62 per diluted share, as compared to $319.5 million, or $4.84 per diluted share, during the first quarter of 2025. As reflected on the Supplemental Schedule, included in our reported results during the first quarter of 2026 was a favorable net after-tax impact of $2.2 million, or $.03 per diluted share, resulting from the net tax benefit recorded in connection with "ASU 2016-09", Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting, net of the impact of executive compensation limitations pursuant to IRC section 162(m).    As reflected on the Supplemental Schedule, included in our reported results during the first quarter of 2025 were: (i) an unrealized after-tax loss (included in "Other (income) expense, net") of $3.3 million, or $.05 per diluted share ($4.3 million pre-tax), resulting from a decrease in the market value of certain equity securities (that were sold during the fourth quarter of 2025), and; (ii) a favorable net after-tax impact of $0.5 million, or $.01 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09.     As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization ("EBITDA net of NCI", NCI is net income attributable to noncontrolling interests), was $651.7 million during the first quarter of 2026, as compared to $603.9 million during the first quarter of 2025. Our adjusted earnings before interest, taxes, depreciation & amortization ("Adjusted EBITDA net of NCI"), which excludes the impact of other (income) expense, net, was $648.3 million during the first quarter of 2026, as compared to $598.2 million during the first quarter of 2025.Acute Care Services – Three-month periods ended March 31, 2026 and 2025:During the first quarter of 2026, at our acute care hospitals owned during both periods ("same facility basis"), adjusted admissions (adjusted for outpatient activity) were unchanged and adjusted patient days increased by 0.8%, as compared to the first quarter of 2025. At these facilities, during the first quarter of 2026, net revenue per adjusted admission increased by 6.3% while net revenue per adjusted patient day increased by 5.5%, as compared to the first quarter of 2025. Net revenues generated from our acute care services, on a same facility basis, increased by 8.2% during the first quarter of 2026, as compared to the first quarter of 2025.Behavioral Health Care Services – Three-month periods ended March 31, 2026 and 2025:During the first quarter of 2026, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 1.2% while adjusted patient days increased by 1.6%, as compared to the first quarter of 2025. At these facilities, during the first quarter of 2026, net revenue per adjusted admission increased by 6.2% and net revenue per adjusted patient day increased by 5.8%, as compared to the first quarter of 2025. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 7.3% during the first quarter of 2026, as compared to the first quarter of 2025.Net Cash Provided by Operating Activities and Credit Agreement Amendment/Capital Resources:Net Cash Provided by Operating Activities:During the three-month period ended March 31, 2026, our net cash provided by operating activities was $402 million as compared to $360 million during the first quarter of 2025. The $42 million net increase in our net cash provided by operating activities consisted of: (i) a favorable change of $40 million resulting from an increase in net income plus/minus depreciation and amortization expense, stock-based compensation expense and gain on sales of assets and businesses; (ii) a favorable change of $95 million in accounts receivable (due, in part, to delays experienced during the first quarter of 2025 in receipt of funds in connection with certain Medicaid supplemental payment programs in various states); (iii) an unfavorable change of $80 million in other working capital accounts due primarily to the timing of accounts payable disbursements, and; (iv) other combined net unfavorable changes of $13 million.  Credit Agreement Amendment/Capital Resources:In April, 2026, and as previously disclosed on Form 8-K as filed with the Securities and Exchange Commission on April 24, 2026, we amended our credit agreement to, among other things, increase our borrowing capacity by an aggregate of $900 million as follows: (i) increase the borrowing capacity of the revolving credit facility by $200 million to $1.5 billion (from $1.3 billion previously); (ii) increase the existing tranche term loan A by $300 million to $1.455 billion (from $1.155 billion previously), and; (iii) initiate a new $400 million delayed draw term loan A which is expected to be drawn upon the closing of our acquisition of Talkspace, Inc. The maturity date for our credit agreement, which is scheduled for September 26, 2029, remained unchanged.     As of March 31, 2026, we had approximately $373 million of borrowings outstanding pursuant to our revolving credit facility.Stock Repurchase Program:In connection with our stock repurchase program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions. Pursuant to this program, during the first quarter of 2026, we have repurchased 675,000 shares at an aggregate cost of approximately $127.3 million (average price of approximately $189 per share).As of March 31, 2026, we had an aggregate available repurchase authorization of approximately $1.298 billion pursuant to our stock repurchase program.Conference call information:We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on April 28, 2026. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call. Supplemental financial disclosures related to our financial results are available on our website.General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. (the "Company") has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500® corporation, our annual revenues during 2025 were $17.4 billion. UHS ranked #271 on the Fortune 500® and #355 among American companies on the Forbes Global 2000. In 2026, UHS was again recognized as one of Fortune World's Most Admired Companies™ (from Fortune, ©2025, 2026 Fortune Media IP Limited. All rights reserved. Used under license).Our operating philosophy is as effective today as it was upon the Company's founding in 1979, enabling us to provide compassionate care to our patients and their loved ones.  Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.UHS is headquartered in King of Prussia, PA, and, through its subsidiaries, has approximately 101,500 employees and operates 29 inpatient acute care hospitals, 346 inpatient behavioral health facilities, 168 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico.A wholly-owned subsidiary of UHS acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT).  For additional information visit www.uhs.com.This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2025), may cause the results to differ materially from those anticipated in the forward-looking statements.  These statements are subject to risks and uncertainties and therefore actual results may differ materially.  Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof.  We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions.  Changes to these programs could materially affect program payments which could materially impact our results of operations. In addition, we receive substantial reimbursement from multiple states in connection with various supplemental Medicaid payment programs. Failure to renew these programs beyond their scheduled termination dates, failure of the public hospitals to provide the necessary Inter-Governmental Transfers for the states' share of the Medicaid disproportionate share hospital programs, and the failure of our hospitals that currently receive supplemental Medicaid revenues to qualify for future funds under these programs could cause our actual results of operations for the year ended December 31, 2026 to differ materially from our previously disclosed 2026 operating results forecast.Legislation adopted on July 4, 2025, attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditures. That legislation also places limits on provider fees used to increase federal Medicaid funding to states and eliminated certain exchange premium tax credits beyond 2025. As these provisions become effective over the next several years, they may be expected to reduce our revenues and likely increase the level of uncompensated care provided by our facilities.The increase in interest rates during the past few years has increased our interest expense significantly thereby reducing our free cash flow. As such, although interest rates have moderated more recently, the effects of increased borrowing rates have adversely impacted our results of operations, financial condition and cash flows. We cannot predict future changes to interest rates, however, significant increases in our borrowing rates could have a material unfavorable impact on our future results of operations and our ability to access the capital markets on favorable terms.Changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where our products or materials are made (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results.      The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries, including, but not limited to, the matters related to Cumberland Hospital for Children and Adolescents, located in New Kent, Virginia, and the verdict in Washoe County, Nevada, against certain subsidiaries of ours, both of which were previously disclosed in various filings including, most recently, our Form 10-K for the year ended December 31, 2025. Although we can make no assurances regarding the ultimate outcome of these matters, or what damages will ultimately be awarded, the final resolution of these matters could have a material adverse effect on the Company.The ability to successfully complete, integrate and realize the benefit and synergies from our proposed acquisition of Talkspace, Inc. We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2025. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance. Universal Health Services, Inc.Consolidated Statements of Income(in thousands, except per share amounts)(unaudited)




Three months
ended March 31,
2026
2025



Net revenues$4,495,182
$4,099,720



Operating charges:


   Salaries, wages and benefits2,088,229
1,951,104   Other operating expenses1,283,928
1,105,752   Supplies expense426,543
402,881   Depreciation and amortization155,426
148,345   Lease and rental expense38,196
36,813
3,992,322
3,644,895



Income from operations502,860
454,825



Interest expense, net37,133
40,056Other (income) expense, net(3,389)
(5,659)



Income before income taxes469,116
420,428



Provision for income taxes110,438
98,800



Net income358,678
321,628



Less:  Net income (loss) attributable to


noncontrolling interests ("NCI")9,996
4,948



Net income attributable to UHS$348,682
$316,680























Basic earnings per share attributable to UHS (a)$5.71
$4.87



Diluted earnings per share attributable to UHS (a)$5.65
$4.80
 Universal Health Services, Inc.Footnotes to Consolidated Statements of Income(in thousands, except per share amounts)(unaudited)




Three months(a) Earnings per share calculation:ended March 31,
2026
2025Basic and diluted:


Net income attributable to UHS - basic and diluted$348,682
$316,680



Weighted average number of common shares - basic61,071
64,970



Basic earnings per share attributable to UHS:$5.71
$4.87



Weighted average number of common shares61,071
64,970Add: Other share equivalents597
1,067Weighted average number of common shares and equiv. - diluted61,668
66,037



Diluted earnings per share attributable to UHS:$5.65
$4.80



 Universal Health Services, Inc.Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")For the Three Months ended March 31, 2026 and 2025(in thousands, except per share amounts)(unaudited)























Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization
("EBITDA/Adjusted EBITDA net of NCI")








Three months ended
% Net
Three months ended
% Net
March 31, 2026
revenues
March 31, 2025
revenues







Net income attributable to UHS$348,682


$316,680

   Depreciation and amortization155,426


148,345

   Interest expense, net37,133


40,056

   Provision for income taxes110,438


98,800

EBITDA net of NCI$651,679
14.5 %
$603,881
14.7 %







Other (income) expense, net(3,389)


(5,659)

Adjusted EBITDA net of NCI$648,290
14.4 %
$598,222
14.6 %







Net revenues$4,495,182


$4,099,720









































Calculation of Adjusted Net Income Attributable to UHS








Three months ended
Three months ended
March 31, 2026
March 31, 2025


Per


Per
Amount
Diluted Share
Amount
Diluted Share







Net income attributable to UHS$348,682
$5.65
$316,680
$4.80Plus/minus after-tax adjustments:






Loss on marketable equity securities-
-
3,285
0.05Impact of ASU 2016-09, net(2,164)
(0.03)
(461)
(0.01)Subtotal adjustments(2,164)
(0.03)
2,824
0.04Adjusted net income$346,518
$5.62
$319,504
$4.84







 Universal Health Services, Inc.Condensed Consolidated Balance Sheets(in thousands)(unaudited)









March 31,

December 31,


2026

2025Assets





Current assets:





    Cash and cash equivalents
$119,028
$137,797    Accounts receivable, net

2,745,090

2,602,434    Supplies

229,415

232,110    Other current assets

406,168

435,574          Total current assets

3,499,701

3,407,915






Property and equipment

13,609,793

13,489,811Less: accumulated depreciation

(6,546,146)

(6,481,714)


7,063,647

7,008,097






Other assets:





    Goodwill

3,980,656

3,990,213    Deferred income taxes

68,339

70,517    Right of use assets-operating leases

375,316

374,239    Deferred charges

9,234

9,272    Other

684,249

667,340Total Assets
$15,681,142
$15,527,593






Liabilities and Stockholders' Equity





Current liabilities:





    Current maturities of long-term debt
$756,240
$748,158    Accounts payable and other liabilities

2,356,343

2,416,276    Operating lease liabilities

72,904

73,237    Federal and state taxes

58,591

1,930          Total current liabilities

3,244,078

3,239,601






Other noncurrent liabilities

532,678

527,827Operating lease liabilities noncurrent

344,555

340,715Deferred income taxes

3,234

5,649Long-term debt

3,952,118

4,004,393






Redeemable noncontrolling interest

73,380

70,620






UHS common stockholders' equity

7,464,857

7,275,792Noncontrolling interest

66,242

62,996          Total equity

7,531,099

7,338,788






Total Liabilities and Stockholders' Equity
$15,681,142
$15,527,593






 Universal Health Services, Inc.Consolidated Statements of Cash Flows(in thousands)(unaudited)
Three months
ended March 31,
2026
2025



Cash Flows from Operating Activities:


  Net income$358,678
$321,628  Adjustments to reconcile net income to net 


cash provided by operating activities:


Depreciation & amortization155,426
148,345Stock-based compensation expense22,504
21,595Gain on sales of assets and businesses(5,046)
0  Changes in assets & liabilities, net of effects from


acquisitions and dispositions:


   Accounts receivable(123,862)
(218,374)   Accrued interest10,992
11,086   Accrued and deferred income taxes 104,772
88,641   Other working capital accounts (122,911)
(42,824)   Other assets and deferred charges(12,257)
(489)   Other, net (221)
3,811   Accrued insurance expense, net of commercial premiums paid62,568
47,334   Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements(49,015)
(20,705)          Net cash provided by operating activities401,628
360,048



Cash Flows from Investing Activities:


   Property and equipment additions(217,157)
(239,026)   Proceeds received from sales of assets and businesses14,304
0   Acquisition of businesses and property(4,857)
(8,314)   Inflows (outflows) from foreign exchange contracts that hedge our net U.K. investment14,716
(23,695)   Costs incurred for purchase and development of enterprise resource planning application(4,613)
0   Decrease (increase) in capital reserves of commercial insurance subsidiary 28
(264)          Net cash used in investing activities(197,579)
(271,299)



Cash Flows from Financing Activities:


   Repayments of long-term debt(44,731)
(9,113)   Additional borrowings40
152,454   Repurchase of common shares(163,849)
(223,385)   Dividends paid(12,974)
(13,534)   Issuance of common stock3,782
3,658   Profit distributions to noncontrolling interests(7,912)
(5,912)   Purchase of ownership interests by minority members, net3,750
4,412          Net cash used in financing activities(221,894)
(91,420)



   Effect of exchange rate changes on cash and cash equivalents(924)
1,645Decrease in cash, cash equivalents and restricted cash(18,769)
(1,026)Cash, cash equivalents and restricted cash, beginning of period271,322
224,752Cash, cash equivalents and restricted cash, end of period$252,553
$223,726



Supplemental Disclosures of Cash Flow Information:


  Interest paid$25,119
$27,718



  Income taxes paid, net of refunds$8,276
$5,638



  Noncash purchases of property and equipment$70,246
$116,196







 Universal Health Services, Inc.Supplemental Statistical Information(unaudited)


















 % Change 





Three Months ended
Same Facility:



3/31/2026







Acute Care Hospitals (1)





Revenues



8.2 %
Adjusted Admissions



0.0 %
Adjusted Patient Days



0.8 %
Revenue Per Adjusted Admission



6.3 %
Revenue Per Adjusted Patient Day



5.5 %







Behavioral Health Hospitals (1)





Revenues



7.3 %
Adjusted Admissions



1.2 %
Adjusted Patient Days



1.6 %
Revenue Per Adjusted Admission



6.2 %
Revenue Per Adjusted Patient Day



5.8 %







UHS Consolidated

Three Months ended



3/31/2026
3/31/2025







Revenues

$4,495,182
$4,099,720
EBITDA net of NCI

$651,679
$603,881
EBITDA Margin net of NCI

14.5 %
14.7 %
Adjusted EBITDA net of NCI

$648,290
$598,222
Adjusted EBITDA Margin net of NCI
14.4 %
14.6 %







Cash Flow From Operations

$401,628
$360,048
Capital Expenditures  

$217,157
$239,026
Days Sales Outstanding

55
53














Debt 

$4,708,358
$4,649,682
UHS' Shareholders Equity

$7,464,857
$6,785,604
Debt / Total Capitalization

38.7 %
40.7 %
Debt / EBITDA net of NCI (2)

1.70
2.00
Debt / Adjusted EBITDA net of NCI (2)
1.78
2.01
Debt / Cash From Operations (2)

2.47
2.29







(1) Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of January 1, 2025 to conform with current year presentation.(2) Latest 4 quarters.





 Universal Health Services, Inc.

Acute Care Hospital Services

For the Three Months ended

March 31, 2026 and 2025

(in thousands)

(unaudited)













Same Facility Basis - Acute Care Hospital Services
























Three months ended
Three months ended




March 31, 2026
March 31, 2025




Amount
% of Net
Revenues 
Amount
% of Net
Revenues 


Net revenues
$2,470,045
100.0 %
$2,281,831
100.0 %


Operating charges:










Salaries, wages and benefits
952,835
38.6 %
913,829
40.0 %


Other operating expenses
728,152
29.5 %
638,599
28.0 %


Supplies expense
365,497
14.8 %
348,824
15.3 %


Depreciation and amortization
95,681
3.9 %
94,901
4.2 %


Lease and rental expense
26,738
1.1 %
25,344
1.1 %


Subtotal-operating expenses
2,168,903
87.8 %
2,021,497
88.6 %


Income from operations
301,142
12.2 %
260,334
11.4 %


Interest expense, net 
986
0.0 %
2,262
0.1 %


Other (income) expense, net 
(2,555)
(0.1) %
(8,572)
(0.4) %


Income before income taxes
$302,711
12.3 %
$266,644
11.7 %






































All Acute Care Hospital Services
























Three months ended
Three months ended




March 31, 2026
March 31, 2025




Amount
% of Net
Revenues
Amount
% of Net
Revenues 


Net revenues
$2,610,136
100.0 %
$2,357,814
100.0 %


Operating charges:










Salaries, wages and benefits
972,846
37.3 %
915,524
38.8 %


Other operating expenses
859,847
32.9 %
716,662
30.4 %


Supplies expense
367,938
14.1 %
348,692
14.8 %


Depreciation and amortization
96,318
3.7 %
94,903
4.0 %


Lease and rental expense
26,572
1.0 %
25,344
1.1 %


Subtotal-operating expenses
2,323,521
89.0 %
2,101,125
89.1 %


Income from operations
286,615
11.0 %
256,689
10.9 %


Interest expense, net 
986
0.0 %
2,262
0.1 %


Other (income) expense, net 
(2,132)
(0.1) %
(8,267)
(0.4) %


Income before income taxes
$287,761
11.0 %
$262,694
11.1 %


























We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025.











Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of January 1, 2025 to conform with current year presentation.











The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months. Universal Health Services, Inc.

Behavioral Health Care Services

For the Three Months ended

March 31, 2026 and 2025

(in thousands)

(unaudited)













Same Facility Basis - Behavioral Health Care Services






















Three months ended
Three months ended




March 31, 2026
March 31, 2025




Amount
% of Net
Revenues 
Amount
% of Net
Revenues 


Net revenues
$1,818,676
100.0 %
$1,694,160
100.0 %


Operating charges:










Salaries, wages and benefits
993,038
54.6 %
919,790
54.3 %


Other operating expenses
334,423
18.4 %
319,600
18.9 %


Supplies expense
58,456
3.2 %
54,995
3.2 %


Depreciation and amortization
55,156
3.0 %
50,879
3.0 %


Lease and rental expense
11,305
0.6 %
10,878
0.6 %


Subtotal-operating expenses
1,452,378
79.9 %
1,356,142
80.0 %


Income from operations
366,298
20.1 %
338,018
20.0 %


Interest expense, net 
1,192
0.1 %
1,075
0.1 %


Other (income) expense, net 
(883)
(0.0) %
(825)
(0.0) %


Income before income taxes
$365,989
20.1 %
$337,768
19.9 %






































All Behavioral Health Care Services
























Three months ended
Three months ended




March 31, 2026
March 31, 2025




Amount
% of Net
Revenues
Amount
% of Net
Revenues 


Net revenues
$1,882,152
100.0 %
$1,739,064
100.0 %


Operating charges:










Salaries, wages and benefits
1,001,094
53.2 %
923,366
53.1 %


Other operating expenses
391,898
20.8 %
362,262
20.8 %


Supplies expense
58,787
3.1 %
55,148
3.2 %


Depreciation and amortization
56,634
3.0 %
51,152
2.9 %


Lease and rental expense
11,515
0.6 %
11,364
0.7 %


Subtotal-operating expenses
1,519,928
80.8 %
1,403,292
80.7 %


Income from operations
362,224
19.2 %
335,772
19.3 %


Interest expense, net 
1,272
0.1 %
1,075
0.1 %


Other (income) expense, net 
(883)
(0.0) %
(825)
(0.0) %


Income before income taxes
$361,835
19.2 %
$335,522
19.3 %

















We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025.


Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of January 1, 2025 to conform with current year presentation.


The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.  Universal Health Services, Inc.Selected Hospital StatisticsFor the Three Months endedMarch 31, 2026 and 2025(unaudited)












AS REPORTED:


























ACUTE
BEHAVIORAL HEALTH

3/31/26
3/31/25
%  change
3/31/26
3/31/25
%  change












Hospitals owned and leased
29
28
3.6 %
346
334
3.6 %Average licensed beds
7,165
6,994
2.4 %
24,570
24,083
2.0 %Average available beds
6,993
6,822
2.5 %
24,470
23,983
2.0 %Patient days
431,073
429,030
0.5 %
1,619,586
1,588,545
2.0 %Average daily census
4,789.7
4,767.0
0.5 %
17,995.4
17,650.5
2.0 %Occupancy-licensed beds
66.8 %
68.2 %
-1.9 %
73.2 %
73.3 %
-0.1 %Occupancy-available beds
68.5 %
69.9 %
-2.0 %
73.5 %
73.6 %
-0.1 %Admissions
87,889
88,090
-0.2 %
117,491
116,350
1.0 %Length of stay
4.9
4.9
0.0 %
13.8
13.7
0.7 %












Inpatient revenue
$15,963,182
$14,318,291
11.5 %
$3,266,302
$2,844,888
14.8 %Outpatient revenue
10,812,978
9,327,796
15.9 %
312,492
274,034
14.0 %Total patient revenue
26,776,160
23,646,087
13.2 %
3,578,794
3,118,922
14.7 %Other revenue
337,257
280,443
20.3 %
95,475
88,379
8.0 %Gross revenue
27,113,417
23,926,530
13.3 %
3,674,269
3,207,301
14.6 %Total deductions
24,503,281
21,568,716
13.6 %
1,792,117
1,468,237
22.1 %Net revenue 
$2,610,136
$2,357,814
10.7 %
$1,882,152
$1,739,064
8.2 %

























SAME FACILITY:


























ACUTE
BEHAVIORAL HEALTH

3/31/26
3/31/25
%  change
3/31/26
3/31/25
%  change












Hospitals owned and leased
28
28
0.0 %
334
334
0.0 %Average licensed beds
7,023
6,994
0.4 %
24,016
23,856
0.7 %Average available beds
6,851
6,822
0.4 %
23,916
23,756
0.7 %Patient days
425,835
429,030
-0.7 %
1,593,351
1,570,599
1.4 %Average daily census
4,731.5
4,767.0
-0.7 %
17,703.9
17,451.1
1.4 %Occupancy-licensed beds
67.4 %
68.2 %
-1.2 %
73.7 %
73.2 %
0.8 %Occupancy-available beds
69.1 %
69.9 %
-1.2 %
74.0 %
73.5 %
0.8 %Admissions
86,780
88,090
-1.5 %
116,268
115,049
1.1 %Length of stay
4.9
4.9
0.0 %
13.7
13.7
0.0 %

























Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of January 1, 2025 to conform with current year presentation. 



View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-financial-results-for-the-three-month-period-ended-march-31-2026-302754586.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE-MONTH PERIOD ENDED MARCH 31, 2026

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALLApril 6, 2026 4:14 PM
PR Newswire (US)

KING OF PRUSSIA, Pa., April 6, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2026, after the market closes on Monday, April 27, 2026. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Tuesday, April 28, 2026.              A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico. 



View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-date-for-first-quarter-2026-earnings-release-and-conference-call-302734835.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2026 EARNINGS RELEASE AND CONFERENCE CALL

Universal Health Services, Inc. to Acquire Talkspace, Inc.March 9, 2026 7:39 AM
PR Newswire (US)

Industry-leading virtual behavioral healthcare platform accelerates outpatient strategy with expanded access to careKING OF PRUSSIA, Pa. and NEW YORK, March 9, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it has entered into a definitive agreement to acquire Talkspace, Inc. (NASDAQ: TALK) for $5.25 per share. The enterprise value for the transaction is approximately $835 million, which UHS intends to finance with borrowings pursuant to its existing revolving credit facility.







Talkspace is a leading virtual behavioral healthcare company, with a network of approximately 6,000 licensed professionals that serve all 50 states, Washington, D.C., and Puerto Rico. As of December 31, 2025, Talkspace's services were available to more than 200 million individuals through their health insurance plans, employee assistance programs, or as a benefit through their employer, school or government agency. Talkspace generated $229 million in revenue and provided more than 1.6 million therapy and psychiatry sessions in 2025."Talkspace's patient-centric, clinically driven virtual platform perfectly complements the high-quality services delivered at our facilities, enabling us to expand access and offer more flexible, stepped solutions to address the growing demand for behavioral healthcare," said Marc D. Miller, President and CEO of UHS. "This acquisition aligns with UHS' core growth objectives by accelerating our outpatient and telehealth behavioral health strategies, diversifying our payor mix and delivering a comprehensive, technology-enabled continuum of care that supports innovative approaches to mental health services.""Over the past several years, Talkspace has transformed from a direct-to-consumer pioneer into a scaled, insurance-covered behavioral healthcare platform trusted by patients, providers, payors and employers," said Jon R. Cohen, MD, CEO ofTalkspace. "This transaction reflects the next logical step in expanding access to affordable, high- quality mental healthcare by integrating outpatient virtual care into a modern behavioral health ecosystem."Strategic and Financial BenefitsTalkspace's 6,000 providers and trusted virtual behavioral health platform will support the creation of the industry's first nationally scaled, end-to-end continuum in behavioral healthcare. These new capabilities deliver a patient-centered virtual offering that facilitates seamless transitions across care settings and improves access for payors and consumers alike.Excluding one-time costs related to the acquisition, the transaction is expected to be slightly accretive to UHS' adjusted net income attributable to UHS per diluted share (as defined below) duringthe first twelve months post-closing and increasingly accretive thereafter. The acquisition broadens UHS' access to commercially insured populations nationwide, serving to diversify payor mix while laying a scalable platform for sustained growth through expanded and new outpatient and virtual behavioral health services.Transaction Timing and ApprovalsThe transaction was unanimously approved by the respective Boards of Directors of UHS and Talkspace.The transaction, which is expected to close during the third quarter of 2026, is subject to approval by Talkspace's stockholders, satisfaction of regulatory approvals and other customary closing conditions.Webcast InformationUHS management expects to discuss the acquisition during its presentation at the Leerink Partners Global Healthcare Conference on Monday, March 9, 2026, at 8:00am ET. A link to the webcast can be found in the investor relations section of thecompany's website at www.uhs.com .AdvisorsUHS' financial advisor is J.P. Morgan Securities LLC and its legal counsels are McDermott Will & Schulte and Stevens & Lee.Talkspace's financial advisor is Wells Fargo Securities, LLC and its legal counsel is Cravath, Swaine & Moore LLP.Forward-Looking StatementsThis press release contains "forward-looking" statements based on UHS and/or Talkspace's management expectations. Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in UHS and Talkspace's respective filings with the Securities and Exchange Commission (the " SEC") (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in UHS' Annual Report on Form 10-K for the year ended December 31, 2025 and Talkspace's Annual Report on Form 10-K for the year ended December 31, 2024), may cause the results to differ materially from those anticipated in the forward-looking statements. These statements are subject to risks and uncertainties and therefore actual results may differ materially. Those risks and uncertainties include: the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement or the failure to satisfy the closing conditions; the possibility that the consummation of the proposed acquisition is delayed or does not occur, including the failure of Talkspace's stockholders to approve the proposed merger; uncertainty as to whether the parties will be able to complete the merger on the terms set forth in the merger agreement; uncertainty regarding the timing of the receipt of required regulatory approvals for the merger and the possibility that the parties may be required to accept conditions that could reduce or eliminate the anticipated benefits of the merger as a condition to obtaining regulatory approvals or that the required regulatory approvals might not be obtained at all; risks related to the possibility that competing offers or acquisition proposals for Talkspace will be made; the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive transaction agreement relating to the proposed transaction, including in circumstances which would require Talkspace to pay a termination fee; the outcome of any legal proceedings that may be instituted against the parties or others following announcement of the transactions contemplated by the merger agreement; challenges, disruptions and costs of closing, integrating the business and achieving anticipated synergies, or that such synergies will take longer to realize than expected; failure to retain key employees of Talkspace during the period prior to closing or thereafter; failure to retain a significant portion of Talkspace's providers or relationships with payors, risks that the merger and other transactions contemplated by the merger agreement disrupt current plans and operations that may harm the parties' businesses or divert management's attention from the parties' ongoing business operations; the amount of any costs, fees, expenses, impairments and charges related to the merger including costs and use of capital related to financing the merger; and uncertainty as to the effects of the announcement or pendency of the proposed merger on the market price of UHS' and/or Talkspace's common stock and/or on their respective financial performances. Readers should not place undue reliance on such forward-looking statements which reflect UHS and/or Talkspace's management's view only as of the date hereof. Neither UHS nor Talkspace undertakes any obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.Additional Information and Where to Find ItThis communication may be deemed to be solicitation material in respect of the proposed acquisition of Talkspace by UHS. In connection with the proposed transaction, Talkspace intends to file relevant materials with the SEC, including Talkspace's proxy statement in preliminary and definitive form. INVESTORS AND STOCKHOLDERS OF TALKSPACE ARE URGED TO READ ALL RELEVANT DOCUMENTS FILED WITH THE SEC, INCLUDING TALKSPACE'S PROXY STATEMENT (IF AND WHEN AVAILABLE), AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS THERETO, CAREFULLY WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION. Investors and security holders are or will be able to obtain the documents ( if and when available) free of charge at the SEC's website at www.sec.gov or from Talkspace's investor relations webpage at https://investors.talkspace.com/ .Participants in the SolicitationTalkspace and its directors, executive officers and certain other members of management and employees may, under SEC rules, be deemed to be "participants" in the solicitation of proxies from Talkspace's stockholders in favor of the proposed transaction. Information about Talkspace's directors and executive officers is set forth in Talkspace's Proxy Statement on Schedule 14A for its 2025 Annual Meeting of stockholders, which was filed with the SEC on April 30, 2025. To the extent holdings of Talkspace's securities by its directors or executive officers have changed since the amounts set forth in such 2025 proxy statement, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Change in Ownership on Form 4 filed with the SEC. Additional information concerning the interests of participants in the solicitation, which may, in some cases, be different than those of Talkspace's stockholders generally, will be set forth in Talkspace's proxy statement relating to the proposed transaction when it becomes available.Universal Health Services, Inc.One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500® corporation, our annual revenues during 2025 were approximately $17.4 billion. In 2026, UHS was again recognized as one of Fortune World's Most Admired Companies™; and in 2025, ranked #271 on the Fortune 500®; and ranked #355 among U.S. companies on Forbes Global 2000 World's Largest Public Companies.UHS is h eadquartered in King of Prussia, PA, and, through its subsidiaries, has approximately 101,500 employees andoperates 29 inpatient acute care facilities, 346 inpatient behavioral health facilities and 168 outpatient and other facilitiesand ambulatory care access points, an insurance offering, a physician network and various related services located in 40 U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT).For additional information visit www.uhs.com .From Fortune , ©2025, 2026 *Fortune * Media IP Limited. All rights reserved. Used under license.TalkspaceTalkspace (NASDAQ: TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. Talkspace pioneered the ability to text with a licensed therapist from anywhere and now offers a comprehensive suite of mental health services, including therapy for individuals, teens, and couples, as well as psychiatric treatment and medication management (18+). With Talkspace's core therapy offerings, members are matched with one of thousands of licensed therapists within days and can engage in live video, audio, or chat sessions, and/or unlimited asynchronous text messaging sessions.All care offered at Talkspace is delivered through an easy-to-use, fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. Most Americans have access to Talkspace through their health insurance plans, employee assistance programs, our partnerships with leading healthcare companies, or as a free benefit through their employer, school, or government agency.For more information, visit www.talkspace.comContacts
UHS
Investors: Darren Lehrich, darren.lehrich@uhsinc.om
Media: mediarelations@uhsinc.comTalkspace
Investors: talkspaceir@icrhealthcare.com 
Media: Press@talkspace.com










View original content to download multimedia:https://www.prnewswire.com/news-releases/universal-health-services-inc-to-acquire-talkspace-inc-302708096.htmlSOURCE Universal Health Services, Inc.

Original: Universal Health Services, Inc. to Acquire Talkspace, Inc.

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE-MONTH PERIODS ENDED DECEMBER 31, 2025 AND OPERATING RESULTS FORECAST FOR THE FULL YEAR OF 2026February 25, 2026 4:16 PM
PR Newswire (US)

Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended December 31, 2025 and 2024:KING OF PRUSSIA, Pa., Feb. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $445.9 million, or $7.06 per diluted share, during the fourth quarter of 2025, as compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024.  Net revenues increased by 9.1% to $4.486 billion during the fourth quarter of 2025, as compared to $4.114 billion during the fourth quarter of 2024.As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our adjusted net income attributable to UHS during the fourth quarter of 2025 was $371.4 million, or $5.88 per diluted share, as compared to $329.9 million, or $4.92 per diluted share, during the fourth quarter of 2024. As reflected on the Supplemental Schedule, included in our reported results during the fourth quarter of 2025 were: (i) an after-tax unrealized gain of $71.5 million, or $1.13 per diluted share ($93.3 million pre-tax), recorded in connection with our minority ownership in a healthcare generative artificial intelligence company (included in "Other (income) expense, net"); (ii) an after-tax gain of $0.8 million, or $.01 per diluted share ($1.0 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025 (included in "Other (income) expense, net"), and; (iii) a favorable net after-tax impact of $2.3 million, or $.04 per diluted share, resulting from the net tax benefit recorded in connection with "ASU 2016-09", Compensation – Stock Compensation: Improvements to Employee Share-Based Payment Accounting, net of the impact of executive compensation limitations pursuant to IRC section 162(m).    As reflected on the Supplemental Schedule, included in our reported results during the fourth quarter of 2024 were: (i) an unrealized after-tax gain of $2.1 million, or $.03 per diluted share ($2.7 million pre-tax), resulting from an increase in the market value of certain equity securities (included in "Other (income) expense, net"), and; (ii) a favorable net after-tax impact of $0.4 million, or $.01 per diluted share, resulting from the net tax benefit recorded pursuant to ASU 2016-09.     As calculated on the attached Supplemental Schedule, our earnings before interest, taxes, depreciation & amortization ("EBITDA net of NCI", NCI is net income attributable to noncontrolling interests), was $785.1 million during the fourth quarter of 2025, as compared to $620.2 million during the fourth quarter of 2024. Our adjusted earnings before interest, taxes, depreciation & amortization ("Adjusted EBITDA net of NCI"), which excludes the impact of other (income) expense, net, was $678.7 million during the fourth quarter of 2025, as compared to $614.6 million during the fourth quarter of 2024.Consolidated Results of Operations, As Reported and As Adjusted  – Twelve-month periods ended December 31, 2025 and 2024:Reported net income attributable to UHS was $1.489 billion, or $23.10 per diluted share, during the full year of 2025, as compared to $1.142 billion, or $16.82 per diluted share, during 2024. Net revenues increased by 9.7% to $17.365 billion during the full year of 2025, as compared to $15.828 billion during 2024.As reflected on the Supplemental Schedule, our adjusted net income attributable to UHS during the full year of 2025 was $1.401 billion, or $21.74 per diluted share, as compared to $1.128 billion, or $16.61 per diluted share, during 2024. As reflected on the Supplemental Schedule, included in our reported results during the full year of 2025 were: (i) an after-tax unrealized gain of $71.5 million, or $1.11 per diluted share, recognized in connection with our minority ownership in a healthcare generative artificial intelligence company (included in "Other (income) expense, net"); (ii) an after-tax gain of $12.1 million, or $.19 per diluted share ($15.7 million pre-tax), resulting from an increase in the market value of certain equity securities that were sold during the fourth quarter of 2025 (included in "Other (income) expense, net"), and; (iii) a favorable net after-tax impact of $4.2 million, or $.06 per diluted share, resulting from the net tax benefit recorded in connection with ASU 2016-09.   As reflected on the Supplemental Schedule, included in our reported results during the full year of 2024 were: (i) an unrealized after-tax loss of $2.0 million, or $.03 per diluted share ($2.6 million pre-tax), resulting from a decrease in the market value of certain equity securities (included in "Other (income) expense, net"), and; (ii) a favorable net after-tax impact of $15.9 million, or $.24 per diluted share, resulting from the above-mentioned net tax benefit recorded in connection with ASU 2016-09.     As calculated on the attached Supplemental Schedule, our EBITDA net of NCI, was $2.725 billion during the full year of 2025, as compared to $2.248 billion during 2024. Our Adjusted EBITDA net of NCI, was $2.590 billion during the full year of 2025, as compared to $2.246 billion during 2024.Acute Care Services – Three and twelve-month periods ended December 31, 2025 and 2024:During the fourth quarter of 2025, at our acute care hospitals owned during both periods ("same facility basis"), adjusted admissions (adjusted for outpatient activity) were unchanged while adjusted patient days decreased by 0.7%, as compared to the fourth quarter of 2024. At these facilities, during the fourth quarter of 2025, net revenue per adjusted admission increased by 5.4% while net revenue per adjusted patient day increased by 6.1%, as compared to the fourth quarter of 2024. Net revenues generated from our acute care services, on a same facility basis, increased by 6.9% during the fourth quarter of 2025, as compared to the fourth quarter of 2024.During the twelve-month period ended December 31, 2025, at our acute care hospitals on a same facility basis, adjusted admissions increased by 1.6% while adjusted patient days increased by 0.3%, as compared to the comparable period of 2024. At these facilities, during the full year of 2025, net revenue per adjusted admission increased by 5.4% while net revenue per adjusted patient day increased by 6.8%, as compared to 2024. Net revenues generated from our acute care services, on a same facility basis, increased by 8.5% during 2025, as compared to 2024.Behavioral Health Care Services – Three and twelve-month periods ended December 31, 2025 and 2024:During the fourth quarter of 2025, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 1.8% while adjusted patient days increased by 1.5%, as compared to the fourth quarter of 2024. At these facilities, during the fourth quarter of 2025, net revenue per adjusted admission increased by 5.3% and net revenue per adjusted patient day increased by 5.6%, as compared to the fourth quarter of 2024. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 7.2% during the fourth quarter of 2025, as compared to the fourth quarter of 2024.During the twelve month-period ended December 31, 2025, at our behavioral health care facilities on a same facility basis, adjusted admissions increased by 0.2% while adjusted patient days increased by 0.9%, as compared to the comparable period of 2024. At these facilities, during the full year of 2025, net revenue per adjusted admission increased by 7.5% and net revenue per adjusted patient day increased by 6.8%, as compared to 2024. Net revenues generated from our behavioral health care services, on a same facility basis, increased by 7.7% during 2025, as compared to 2024.Net Cash Provided by Operating Activities and Liquidity:Net Cash Provided by Operating Activities:During the twelve-month period ended December 31, 2025, our net cash provided by operating activities was $1.864 billion as compared to $2.067 billion during the full year of 2024. The $203 million net decrease in our net cash provided by operating activities consisted of: (i) a favorable change of $300 million resulting from an increase in net income plus/minus depreciation and amortization expense, stock-based compensation expense, unrealized gain on non-marketable securities, gains/losses on sales of assets and businesses, and costs related to extinguishment of debt, offset by; (ii) an unfavorable change of $385 million in accounts receivable (due, in part, to a $145 million increase in net receivables recorded in connection with various Medicaid supplemental payment programs and a $50 million increase in accounts receivable related to two relatively recently opened hospitals in Las Vegas, NV, and Washington, D.C.); (iii) an unfavorable change of $67 million in payments made in settlement of self-insurance claims, net of commercial insurance reimbursements, and; (iv) other combined net unfavorable changes of $51 million.  Liquidity:As of December 31, 2025, we had $889 million of aggregate available borrowing capacity pursuant to our $1.3 billion revolving credit facility, net of outstanding borrowings and letters of credit.      Stock Repurchase Program:In connection with our stock repurchase program, shares of our Class B Common Stock may be repurchased, from time to time as conditions allow, on the open market or in negotiated private transactions. As previously announced, in October, 2025, our Board of Directors authorized a $1.5 billion increase to our stock repurchase program.Pursuant to this program, during the fourth quarter of 2025, we have repurchased 1.461 million shares at an aggregate cost of approximately $333.5 million (average price of approximately $228 per share). During the full year of 2025, we have repurchased 4.650 million shares at an aggregate cost of approximately $899.3 million (average price of approximately $193 per share).As of December 31, 2025, we had an aggregate available repurchase authorization of approximately $1.425 billion pursuant to our stock repurchase program.2026 Operating Results Forecast:Reflected below is our 2026 forecasted range for consolidated net revenues, earnings before interest, taxes, depreciation & amortization, and the impacts of other income/expense and net income attributable to noncontrolling interests ("Adjusted EBITDA net of NCI"), net income attributable to UHS per diluted share ("EPS-diluted") and capital expenditures. Our 2026 forecasted range of net income attributable to UHS, and EPS-diluted, exclude certain items as described below because we do not believe we can forecast those items with sufficient accuracy. Adjusted EBITDA net of NCI, is a non-GAAP financial measure and should not be considered a measure of financial performance under GAAP. We believe Adjusted EBITDA net of NCI is helpful to our investors as a measure of our operating performance. Please see the Supplemental Non-GAAP Disclosures - 2026 Operating Results Forecast schedule as included herein for additional information and a reconciliation of our 2026 revised forecasted range of adjusted net income attributable to UHS to our 2026 revised forecasted range of Adjusted EBITDA net of NCI. 
For the Year Ended
December 31, 2026
       Low       High Net revenues$18.417 billion$18.789 billionAdjusted EBITDA net of NCI$2.641 billion$2.789 billion EPS-diluted$22.64 per share$24.52 per shareCapital expenditures$950 million$1.1 billionThe midpoint of our 2026 forecasted net revenues represents an increase of 7.1% over our 2025 net revenues of $17.365 billion. The midpoint of our 2026 forecasted Adjusted EBITDA net of NCI, represents an increase of 4.8% over our 2025 Adjusted EBITDA net of NCI, of $2.590 billion.The midpoint of our 2026 forecasted Adjusted EPS-diluted represents an increase of 8.5% over our 2025 Adjusted EPS-diluted of $21.74. Because we do not believe we can forecast certain items with sufficient accuracy, our 2026 forecasted range of Adjusted EBITDA net of NCI, net income attributable to UHS, and Adjusted EPS-diluted, exclude the impact of future items, if applicable, that are nonrecurring or non-operational in nature including items such as changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, other amounts that may be reflected in the current or prior year financial statements that relate to prior periods, and the impact of share repurchases that differ from our forecasted assumptions. It is also subject to certain conditions including those as set forth below in General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures. Conference call information:We will hold a conference call for investors and analysts at 9:00 a.m. eastern time on February 26, 2026. A live webcast of the call will be available on our website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures:One of the nation's largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. (the "Company") has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500® corporation, our annual revenues during 2025 were $17.365 billion. UHS ranked #271 on the Fortune 500® and #355 among American companies on the Forbes Global 2000. In 2026, UHS was again recognized as one of Fortune World's Most Admired Companies™ (from Fortune, ©2025, 2026 Fortune Media IP Limited. All rights reserved. Used under license).Our operating philosophy is as effective today as it was upon the Company's founding in 1979, enabling us to provide compassionate care to our patients and their loved ones.  Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.UHS is headquartered in King of Prussia, PA, and, through its subsidiaries, has approximately 101,500 employees and operates 29 inpatient acute care hospitals, 346 inpatient behavioral health facilities, 168 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. We have changed the method of our outpatient behavioral health care facility counts during the third quarter of 2025 and substantially all the increase from prior periods relates to that change in convention.A wholly-owned subsidiary of UHS acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT).  For additional information visit www.uhs.com.This press release contains forward-looking statements based on current management expectations.  Numerous factors, including those disclosed herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors, and Item 7-Forward-Looking Statements and Risk Factors, in our Form 10-K for the year ended December 31, 2025), may cause the results to differ materially from those anticipated in the forward-looking statements.  These statements are subject to risks and uncertainties and therefore actual results may differ materially.  Readers should not place undue reliance on such forward-looking statements which reflect management's view only as of the date hereof.  We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Many of the factors that could affect our future results are beyond our control or ability to predict, including, but not limited to:A significant portion of our revenues are derived from federal and state government programs including the Medicare and Medicaid programs. Payments from these programs are subject to statutory and regulatory changes, administrative rulings, interpretations and determinations, requirements for utilization review, and federal and state funding restrictions. Changes to these programs could materially affect program payments which could materially impact our results of operations. In addition, we receive substantial reimbursement from multiple states in connection with various supplemental Medicaid payment programs. Failure to renew these programs beyond their scheduled termination dates, failure of the public hospitals to provide the necessary Inter-Governmental Transfers for the states' share of the Medicaid disproportionate share hospital programs, and the failure of our hospitals that currently receive supplemental Medicaid revenues to qualify for future funds under these programs could cause our actual results of operations for the year ended December 31, 2026 to differ materially from our 2026 operating results forecast.Legislation adopted on July 4, 2025, attaches work and community service requirements to eligibility for Medicaid benefits that will have the effect of limiting Medicaid enrollment and expenditures. That legislation also places limits on provider fees used to increase federal Medicaid funding to states and eliminates certain exchange premium tax credits beyond 2025. As these provisions become effective over the next several years, they may be expected to reduce our revenues and likely increase the level of uncompensated care provided by our facilities.The increase in interest rates during the past few years has increased our interest expense significantly thereby reducing our free cash flow. As such, although interest rates have moderated more recently, the effects of increased borrowing rates have adversely impacted our results of operations, financial condition and cash flows. We cannot predict future changes to interest rates, however, significant increases in our borrowing rates could have a material unfavorable impact on our future results of operations and our ability to access the capital markets on favorable terms.Changes in laws or policies governing the terms of foreign trade, and in particular, increased trade restrictions, tariffs or taxes on imports from where our products or materials are made (either directly or through our suppliers) could have an impact on our competitive position, business operations and financial results.The outcome of known and unknown litigation, liabilities and other claims asserted against us and/or our subsidiaries, including, but not limited to, the matters related to Cumberland Hospital for Children and Adolescents, located in New Kent, Virginia, and the verdict in Washoe County, Nevada, against certain subsidiaries of ours, both of which were previously disclosed in various filings including, most recently, our Form 10-K for the year ended December 31, 2025. Although we can make no assurances regarding the ultimate outcome of these matters, or what damages will ultimately be awarded, the final resolution of these matters could have a material adverse effect on the Company.We believe that adjusted net income attributable to UHS, adjusted net income attributable to UHS per diluted share, EBITDA net of NCI and Adjusted EBITDA net of NCI, which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to our investors since it neutralizes the effect of material items impacting our net income attributable to UHS, such as, changes in the value of certain non-marketable securities (in connection with our minority ownership in a healthcare generative artificial intelligence company), the impact of ASU 2016-09, and other potential material items that are nonrecurring or non-operational in nature including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income attributable to UHS, as determined in accordance with GAAP, and as presented in the condensed consolidated financial statements and notes thereto in this report or in our filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2025. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.Universal Health Services, Inc.Consolidated Statements of Income(in thousands, except per share amounts)(unaudited)








Three months
Twelve months
ended December 31,
ended December 31,
2025
2024
2025
2024







Net revenues$4,486,048
$4,113,722
$17,364,829
$15,827,935







Operating charges:






   Salaries, wages and benefits2,046,629
1,907,383
8,084,582
7,518,687   Other operating expenses1,297,207
1,142,901
4,860,246
4,308,384   Supplies expense422,760
405,900
1,659,009
1,587,786   Depreciation and amortization163,334
146,781
618,743
584,831   Lease and rental expense38,886
38,268
148,234
146,433
3,968,816
3,641,233
15,370,814
14,146,121







Income from operations517,232
472,489
1,994,015
1,681,814







Interest expense, net42,217
39,724
156,068
186,109Other (income) expense, net(106,427)
(5,546)
(134,194)
(2,231)







Income before income taxes581,442
438,311
1,972,141
1,497,936







Provision for income taxes133,605
101,264
460,959
334,827







Net income447,837
337,047
1,511,182
1,163,109







Less:  Net income (loss) attributable to






noncontrolling interests ("NCI")1,896
4,650
22,386
21,012







Net income attributable to UHS$445,941
$332,397
$1,488,796
$1,142,097















































Basic earnings per share attributable to UHS (a)$7.19
$5.07
$23.42
$17.16







Diluted earnings per share attributable to UHS (a)$7.06
$4.96
$23.10
$16.82 Universal Health Services, Inc.Footnotes to Consolidated Statements of Income(in thousands, except per share amounts)(unaudited)








Three months
Twelve months(a) Earnings per share calculation:ended December 31,
ended December 31,
2025
2024
2025
2024Basic and diluted:






Net income attributable to UHS$445,941
$332,397
$1,488,796
$1,142,097Less: Net income attributable to unvested restricted share grants0
0
0
(50)Net income attributable to UHS - basic and diluted$445,941
$332,397
$1,488,796
$1,142,047







Weighted average number of common shares - basic62,024
65,597
63,581
66,554







Basic earnings per share attributable to UHS:$7.19
$5.07
$23.42
$17.16







Weighted average number of common shares62,024
65,597
63,581
66,554Add: Other share equivalents1,133
1,477
881
1,342Weighted average number of common shares and equiv. - diluted63,157
67,074
64,462
67,896







Diluted earnings per share attributable to UHS:$7.06
$4.96
$23.10
$16.82 Universal Health Services, Inc.Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")For the Three Months ended December 31, 2025 and 2024(in thousands, except per share amounts)(unaudited)























Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization
("EBITDA/Adjusted EBITDA net of NCI")








Three months ended
% Net
Three months ended
% Net
December 31, 2025
revenues
December 31, 2024
revenues







Net income attributable to UHS$445,941


$332,397

   Depreciation and amortization163,334


146,781

   Interest expense, net42,217


39,724

   Provision for income taxes133,605


101,264

EBITDA net of NCI$785,097
17.5 %
$620,166
15.1 %







Other (income) expense, net(106,427)


(5,546)

Adjusted EBITDA net of NCI$678,670
15.1 %
$614,620
14.9 %







Net revenues$4,486,048


$4,113,722









































Calculation of Adjusted Net Income Attributable to UHS








Three months ended
Three months ended
December 31, 2025
December 31, 2024


Per


Per
Amount
Diluted Share
Amount
Diluted Share







Net income attributable to UHS$445,941
$7.06
$332,397
$4.96Plus/minus after-tax adjustments:






(Gain) loss on marketable equity securities(769)
(0.01)
(2,053)
(0.03)Unrealized gain on non-marketable securities(71,489)
(1.13)
-
-Impact of ASU 2016-09, net(2,284)
(0.04)
(407)
(0.01)Subtotal adjustments(74,542)
(1.18)
(2,460)
(0.04)Adjusted net income attributable to UHS$371,399
$5.88
$329,937
$4.92 Universal Health Services, Inc.Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule")For the Twelve Months ended December 31, 2025 and 2024(in thousands, except per share amounts)(unaudited)























Calculation of Earnings/Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization
("EBITDA/Adjusted EBITDA net of NCI")








Twelve months ended
% Net
Twelve months ended
% Net
December 31, 2025
revenues
December 31, 2024
revenues







Net income attributable to UHS$1,488,796


$1,142,097

   Depreciation and amortization618,743


584,831

   Interest expense, net156,068


186,109

   Provision for income taxes460,959


334,827

EBITDA net of NCI$2,724,566
15.7 %
$2,247,864
14.2 %







Other (income) expense, net(134,194)


(2,231)

Adjusted EBITDA net of NCI$2,590,372
14.9 %
$2,245,633
14.2 %







Net revenues$17,364,829


$15,827,935









































Calculation of Adjusted Net Income Attributable to UHS








Twelve months ended
Twelve months ended
December 31, 2025
December 31, 2024


Per


Per
Amount
Diluted Share
Amount
Diluted Share







Net income attributable to UHS$1,488,796
$23.10
$1,142,097
$16.82Plus/minus after-tax adjustments:






(Gain) loss on marketable equity securities(12,061)
(0.19)
1,985
0.03Unrealized gain on non-marketable securities(71,489)
(1.11)
-
-Impact of ASU 2016-09, net(4,164)
(0.06)
(15,947)
(0.24)Subtotal adjustments(87,714)
(1.36)
(13,962)
(0.21)Adjusted net income attributable to UHS$1,401,082
$21.74
$1,128,135
$16.61 Universal Health Services, Inc.Condensed Consolidated Balance Sheets(in thousands)(unaudited)









December 31,

December 31,


2025

2024Assets





Current assets:





    Cash and cash equivalents
$137,797
$125,983    Accounts receivable, net

2,602,434

2,177,751    Supplies

232,110

220,940    Other current assets

435,574

291,614          Total current assets

3,407,915

2,816,288






Property and equipment

13,489,811

12,643,283Less: accumulated depreciation

(6,481,714)

(6,071,058)


7,008,097

6,572,225






Other assets:





    Goodwill

3,990,213

3,932,879    Deferred income taxes

70,517

118,449    Right of use assets-operating leases

374,239

418,719    Deferred charges

9,272

9,404    Other

667,340

601,785Total Assets
$15,527,593
$14,469,749






Liabilities and Stockholders' Equity





Current liabilities:





    Current maturities of long-term debt
$748,158
$40,059    Accounts payable and other liabilities

2,416,276

2,081,479    Operating lease liabilities

73,237

74,649    Federal and state taxes

1,930

14,219          Total current liabilities

3,239,601

2,210,406






Other noncurrent liabilities

527,827

655,806Operating lease liabilities noncurrent

340,715

376,239Deferred income taxes

5,649

-Long-term debt

4,004,393

4,464,482






Redeemable noncontrolling interest

70,620

13,293






UHS common stockholders' equity

7,275,792

6,666,207Noncontrolling interest

62,996

83,316          Total equity

7,338,788

6,749,523






Total Liabilities and Stockholders' Equity
$15,527,593
$14,469,749 Universal Health Services, Inc.Consolidated Statements of Cash Flows(in thousands)(unaudited)
Twelve months
ended December 31,
2025
2024



Cash Flows from Operating Activities:


  Net income$1,511,182
$1,163,109  Adjustments to reconcile net income to net 


cash provided by operating activities:


Depreciation & amortization618,743
584,831Stock-based compensation expense95,688
99,349Unrealized gain on non-marketable securities(93,291)
0Loss (gain) on sales of assets and businesses7,968
(9,920)Costs related to extinguishment of debt0
3,158  Changes in assets & liabilities, net of effects from


acquisitions and dispositions:


   Accounts receivable(317,985)
67,355   Accrued interest(4,053)
12,814   Accrued and deferred income taxes (21,441)
12,651   Other working capital accounts 99,189
61,897   Other assets and deferred charges(28,599)
(12,163)   Other, net 19,700
21,811   Accrued insurance expense, net of commercial premiums paid236,771
254,394   Payments made in settlement of self-insurance claims, net of commercial insurance reimbursements(259,475)
(192,185)          Net cash provided by operating activities1,864,397
2,067,101



Cash Flows from Investing Activities:


   Property and equipment additions(1,015,152)
(943,810)   Proceeds received from sales of assets and businesses15,863
38,563   Acquisition of businesses and property(47,804)
(18,998)   (Outflows) inflows from foreign exchange contracts that hedge our net U.K. investment(52,213)
12,860   Costs incurred for purchase and development of enterprise resource planning application(24,695)
0Proceeds from sale of marketable equity securities63,073
0Investments in non-marketable securities(9,831)
0   Decrease in capital reserves of commercial insurance subsidiary 142
276          Net cash used in investing activities(1,070,617)
(911,109)



Cash Flows from Financing Activities:


   Repayments of long-term debt(43,504)
(2,640,001)   Additional borrowings285,536
2,210,248   Financing costs(382)
(12,566)   Repurchase of common shares(967,951)
(670,754)   Dividends paid(51,267)
(53,346)   Issuance of common stock16,729
15,070   Profit distributions to noncontrolling interests(11,734)
(6,508)   Purchase of ownership interests by minority members22,846
12,980          Net cash used in financing activities(749,727)
(1,144,877)



   Effect of exchange rate changes on cash and cash equivalents2,517
(833)Increase in cash, cash equivalents and restricted cash46,570
10,282Cash, cash equivalents and restricted cash, beginning of period224,752
214,470Cash, cash equivalents and restricted cash, end of period$271,322
$224,752



Supplemental Disclosures of Cash Flow Information:


  Interest paid$156,041
$168,274



  Income taxes paid, net of refunds$470,865
$325,430



  Noncash purchases of property and equipment$74,423
$118,109 Universal Health Services, Inc.Supplemental Statistical Information(unaudited)


























 % Change 
 % Change 






3 Months ended
12 Months endedSame Facility:





12/31/2025
12/31/2025









Acute Care Hospitals (1)








Revenues





6.9 %
8.5 %Adjusted Admissions





0.0 %
1.6 %Adjusted Patient Days





-0.7 %
0.3 %Revenue Per Adjusted Admission





5.4 %
5.4 %Revenue Per Adjusted Patient Day





6.1 %
6.8 %









Behavioral Health Hospitals (1)








Revenues





7.2 %
7.7 %Adjusted Admissions





1.8 %
0.2 %Adjusted Patient Days





1.5 %
0.9 %Revenue Per Adjusted Admission





5.3 %
7.5 %Revenue Per Adjusted Patient Day





5.6 %
6.8 %









UHS Consolidated

Fourth Quarter Ended
Twelve Months Ended


12/31/2025
12/31/2024
12/31/2025
12/31/2024









Revenues

$4,486,048
$4,113,722
$17,364,829
$15,827,935EBITDA net of NCI

$785,097
$620,166
$2,724,566
$2,247,864EBITDA Margin net of NCI

17.5 %
15.1 %
15.7 %
14.2 %Adjusted EBITDA net of NCI

$678,670
$614,620
$2,590,372
$2,245,633Adjusted EBITDA Margin net of NCI

15.1 %
14.9 %
14.9 %
14.2 %









Cash Flow From Operations

$574,693
$658,437
$1,864,397
$2,067,101Capital Expenditures  

$281,220
$245,945
$1,015,152
$943,810Days Sales Outstanding





55
50



















Debt 





$4,752,551
$4,504,541UHS' Shareholders Equity





$7,275,792
$6,666,207Debt / Total Capitalization





39.5 %
40.3 %Debt / EBITDA net of NCI (2)





1.74
2.00Debt / Adjusted EBITDA net of NCI (2)




1.83
2.01Debt / Cash From Operations (2)





2.55
2.18
(1) Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of May 1, 2024 to conform with current year presentation.(2) Latest 4 quarters.








 Universal Health Services, Inc.Acute Care Hospital ServicesFor the Three and Twelve months endedDecember 31, 2025 and 2024(in thousands)(unaudited)
















Same Facility Basis - Acute Care Hospital Services


































Three months ended
Three months ended
Twelve months ended
Twelve months ended

December 31, 2025
December 31, 2024
December 31, 2025
December 31, 2024

Amount
% of Net
Revenues 
Amount
% of Net
Revenues 
Amount
% of Net
Revenues 
Amount
% of Net
Revenues Net revenues
$2,374,204
100.0 %
$2,220,941
100.0 %
$9,323,647
100.0 %
$8,590,209
100.0 %Operating charges:















Salaries, wages and benefits
947,349
39.9 %
901,004
40.6 %
3,687,017
39.5 %
3,518,909
41.0 %Other operating expenses
692,685
29.2 %
626,978
28.2 %
2,664,397
28.6 %
2,384,758
27.8 %Supplies expense
356,967
15.0 %
348,558
15.7 %
1,397,254
15.0 %
1,360,652
15.8 %Depreciation and amortization
94,702
4.0 %
89,225
4.0 %
361,988
3.9 %
367,822
4.3 %Lease and rental expense
26,222
1.1 %
26,425
1.2 %
100,678
1.1 %
98,777
1.1 %Subtotal-operating expenses
2,117,925
89.2 %
1,992,190
89.7 %
8,211,334
88.1 %
7,730,918
90.0 %Income from operations
256,279
10.8 %
228,751
10.3 %
1,112,313
11.9 %
859,291
10.0 %Interest expense, net 
5,007
0.2 %
2,976
0.1 %
5,975
0.1 %
6,339
0.1 %Other (income) expense, net 
(10,902)
(0.5) %
(775)
(0.0) %
(21,163)
(0.2) %
(1,882)
(0.0) %Income before income taxes
$262,174
11.0 %
$226,550
10.2 %
$1,127,501
12.1 %
$854,834
10.0 %


















































All Acute Care Hospital Services


































Three months ended
Three months ended
Twelve months ended
Twelve months ended

December 31, 2025
December 31, 2024
December 31, 2025
December 31, 2024

Amount
% of Net
Revenues
Amount
% of Net
Revenues 
Amount
% of Net
Revenues
Amount
% of Net
Revenues Net revenues
$2,545,579
100.0 %
$2,326,702
100.0 %
$9,925,907
100.0 %
$8,944,288
100.0 %Operating charges:















Salaries, wages and benefits
976,301
38.4 %
903,457
38.8 %
3,797,810
38.3 %
3,523,526
39.4 %Other operating expenses
828,716
32.6 %
735,765
31.6 %
3,179,922
32.0 %
2,747,066
30.7 %Supplies expense
361,984
14.2 %
348,841
15.0 %
1,426,059
14.4 %
1,360,758
15.2 %Depreciation and amortization
100,398
3.9 %
89,297
3.8 %
388,804
3.9 %
368,717
4.1 %Lease and rental expense
26,501
1.0 %
26,425
1.1 %
101,622
1.0 %
99,066
1.1 %Subtotal-operating expenses
2,293,900
90.1 %
2,103,785
90.4 %
8,894,217
89.6 %
8,099,133
90.6 %Income from operations
251,679
9.9 %
222,917
9.6 %
1,031,690
10.4 %
845,155
9.4 %Interest expense, net 
5,108
0.2 %
2,976
0.1 %
6,285
0.1 %
6,339
0.1 %Other (income) expense, net 
(11,727)
(0.5) %
(951)
(0.0) %
(21,533)
(0.2) %
(1,305)
(0.0) %Income before income taxes
$258,298
10.1 %
$220,892
9.5 %
$1,046,938
10.5 %
$840,121
9.4 %
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Acute Care Hospital Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025.


















Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of May 1, 2024 to conform with current year presentation.


















The All Acute Care Hospital Services table summarizes the results of operations for all our acute care operations during the periods presented. These amounts include: (i) our acute care results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months. Universal Health Services, Inc.Behavioral Health Care ServicesFor the Three and Twelve months endedDecember 31, 2025 and 2024(in thousands)(unaudited)
















Same Facility Basis - Behavioral Health Care Services

































Three months ended
Three months ended
Twelve months ended
Twelve months ended

December 31, 2025
December 31, 2024
December 31, 2025
December 31, 2024

Amount
% of Net
Revenues 
Amount
% of Net
Revenues 
Amount
% of Net
Revenues 
Amount
% of Net
Revenues Net revenues
$1,838,453
100.0 %
$1,715,590
100.0 %
$7,185,336
100.0 %
$6,668,971
100.0 %Operating charges:















Salaries, wages and benefits
986,078
53.6 %
905,324
52.8 %
3,876,831
54.0 %
3,574,879
53.6 %Other operating expenses
339,582
18.5 %
326,173
19.0 %
1,338,907
18.6 %
1,263,911
19.0 %Supplies expense
61,644
3.4 %
57,775
3.4 %
234,606
3.3 %
228,606
3.4 %Depreciation and amortization
58,551
3.2 %
54,562
3.2 %
217,375
3.0 %
204,197
3.1 %Lease and rental expense
11,862
0.6 %
11,243
0.7 %
45,178
0.6 %
45,626
0.7 %Subtotal-operating expenses
1,457,717
79.3 %
1,355,077
79.0 %
5,712,897
79.5 %
5,317,219
79.7 %Income from operations
380,736
20.7 %
360,513
21.0 %
1,472,439
20.5 %
1,351,752
20.3 %Interest expense, net 
596
0.0 %
951
0.1 %
4,021
0.1 %
4,027
0.1 %Other (income) expense, net 
(209)
(0.0) %
(1,139)
(0.1) %
(2,107)
(0.0) %
(3,480)
(0.1) %Income before income taxes
$380,349
20.7 %
$360,701
21.0 %
$1,470,525
20.5 %
$1,351,205
20.3 %


















































All Behavioral Health Care Services


































Three months ended
Three months ended
Twelve months ended
Twelve months ended

December 31, 2025
December 31, 2024
December 31, 2025
December 31, 2024

Amount
% of Net
Revenues
Amount
% of Net
Revenues 
Amount
% of Net
Revenues
Amount
% of Net
Revenues Net revenues
$1,937,516
100.0 %
$1,784,379
100.0 %
$7,425,500
100.0 %
$6,873,090
100.0 %Operating charges:















Salaries, wages and benefits
992,582
51.2 %
908,789
50.9 %
3,893,474
52.4 %
3,590,956
52.2 %Other operating expenses
428,196
22.1 %
391,920
22.0 %
1,566,405
21.1 %
1,443,857
21.0 %Supplies expense
61,878
3.2 %
57,953
3.2 %
235,422
3.2 %
229,527
3.3 %Depreciation and amortization
60,503
3.1 %
55,164
3.1 %
220,464
3.0 %
205,741
3.0 %Lease and rental expense
12,272
0.6 %
11,748
0.7 %
46,257
0.6 %
46,980
0.7 %Subtotal-operating expenses
1,555,431
80.3 %
1,425,574
79.9 %
5,962,022
80.3 %
5,517,061
80.3 %Income from operations
382,085
19.7 %
358,805
20.1 %
1,463,478
19.7 %
1,356,029
19.7 %Interest expense, net 
666
0.0 %
951
0.1 %
4,110
0.1 %
4,027
0.1 %Other (income) expense, net 
(206)
(0.0) %
(1,139)
(0.1) %
(1,135)
(0.0) %
(3,547)
(0.1) %Income before income taxes
$381,625
19.7 %
$358,993
20.1 %
$1,460,503
19.7 %
$1,355,549
19.7 %
We believe that providing our results on a "Same Facility" basis (which is a non-GAAP measure), which includes the operating results for facilities and businesses operated in both the current year and prior year periods, is helpful to our investors as a measure of our operating performance. Our Same Facility results also neutralize (if applicable), the effect of material items that are nonrecurring or non-operational in nature including items such as, but not limited to, reserves for various matters, settlements, legal judgments and lawsuits, cost related to extinguishment of debt, gains/losses on sales of assets and businesses, impairments of goodwill, long-lived and intangible assets and other amounts that may be reflected in the current or prior year financial statements that relate to prior periods. Our Same Facility basis results exclude from net revenues and other operating expenses, provider tax assessments incurred in each period. However, these provider tax assessments are included in net revenues and other operating expenses as reflected in the table under All Behavioral Health Care Services. The provider tax assessments had no impact on the income before income taxes as reflected on the above tables since the amounts offset between net revenues and other operating expenses. To obtain a complete understanding of our financial performance, the Same Facility results should be examined in connection with our net income as determined in accordance with GAAP and as presented herein and the condensed consolidated financial statements and notes thereto as contained in our Form 10-K for the year ended December 31, 2025.


Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of May 1, 2024 to conform with current year presentation.


The All Behavioral Health Care Services table summarizes the results of operations for all our behavioral health care facilities during the periods presented. These amounts include: (i) our behavioral health results on a same facility basis, as indicated above; (ii) the impact of provider tax assessments which increased net revenues and other operating expenses but had no impact on income before income taxes, and; (iii) certain other amounts including the results of facilities acquired or opened during the last twelve months.  Universal Health Services, Inc.Selected Hospital StatisticsFor the Three Months endedDecember 31, 2025 and 2024(unaudited)












AS REPORTED:


























ACUTE
BEHAVIORAL HEALTH

12/31/25
12/31/24
%  change
12/31/25
12/31/24
%  change












Hospitals owned and leased
29
28
3.6 %
345
331
4.2 %Average licensed beds
7,165
6,847
4.6 %
24,436
24,080
1.5 %Average available beds
6,993
6,675
4.8 %
24,336
23,980
1.5 %Patient days
414,230
409,299
1.2 %
1,616,026
1,581,195
2.2 %Average daily census
4,502.5
4,448.9
1.2 %
17,565.5
17,186.9
2.2 %Occupancy-licensed beds
62.8 %
65.0 %
-3.3 %
71.9 %
71.4 %
0.7 %Occupancy-available beds
64.4 %
66.7 %
-3.4 %
72.2 %
71.7 %
0.7 %Admissions
87,277
85,444
2.1 %
115,654
114,236
1.2 %Length of stay
4.7
4.8
-2.1 %
14.0
13.8
1.4 %












Inpatient revenue
$14,235,538
$12,502,393
13.9 %
$3,018,727
$2,740,068
10.2 %Outpatient revenue
9,974,040
8,645,714
15.4 %
296,161
284,689
4.0 %Total patient revenue
24,209,578
21,148,107
14.5 %
3,314,888
3,024,757
9.6 %Other revenue
304,196
251,237
21.1 %
101,945
83,784
21.7 %Gross revenue
24,513,774
21,399,344
14.6 %
3,416,833
3,108,541
9.9 %Total deductions
21,968,195
19,072,642
15.2 %
1,479,317
1,324,162
11.7 %Net revenue 
$2,545,579
$2,326,702
9.4 %
$1,937,516
$1,784,379
8.6 %

























SAME FACILITY:


























ACUTE
BEHAVIORAL HEALTH

12/31/25
12/31/24
%  change
12/31/25
12/31/24
%  change












Hospitals owned and leased
28
28
0.0 %
334
334
0.0 %Average licensed beds
6,923
6,847
1.1 %
24,050
23,895
0.6 %Average available beds
6,751
6,675
1.1 %
23,950
23,795
0.7 %Patient days
404,644
409,299
-1.1 %
1,592,235
1,566,594
1.6 %Average daily census
4,398.3
4,448.9
-1.1 %
17,306.9
17,028.2
1.6 %Occupancy-licensed beds
63.5 %
65.0 %
-2.2 %
72.0 %
71.3 %
1.0 %Occupancy-available beds
65.2 %
66.7 %
-2.3 %
72.3 %
71.6 %
1.0 %Admissions
85,033
85,444
-0.5 %
114,718
113,039
1.5 %Length of stay
4.8
4.8
0.0 %
13.9
13.9
0.0 %












Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of May 1, 2024 to conform with current year presentation. Universal Health Services, Inc.Selected Hospital StatisticsFor the Twelve Months endedDecember 31, 2025 and 2024(unaudited)












AS REPORTED:


























ACUTE
BEHAVIORAL HEALTH

12/31/25
12/31/24
%  change
12/31/25
12/31/24
%  change












Hospitals owned and leased
29
28
3.6 %
345
331
4.2 %Average licensed beds
7,073
6,763
4.6 %
24,342
24,274
0.3 %Average available beds
6,901
6,591
4.7 %
24,242
24,187
0.2 %Patient days
1,657,502
1,621,966
2.2 %
6,476,268
6,426,265
0.8 %Average daily census
4,541.1
4,431.6
2.5 %
17,743.2
17,558.1
1.1 %Occupancy-licensed beds
64.2 %
65.5 %
-2.0 %
72.9 %
72.3 %
0.8 %Occupancy-available beds
65.8 %
67.2 %
-2.1 %
73.2 %
72.6 %
0.8 %Admissions
347,736
334,918
3.8 %
473,071
473,081
0.0 %Length of stay
4.8
4.8
0.0 %
13.7
13.6
0.7 %












Inpatient revenue
$56,351,981
$50,051,514
12.6 %
$11,943,845
$11,088,812
7.7 %Outpatient revenue
38,767,055
34,199,936
13.4 %
1,148,851
1,117,178
2.8 %Total patient revenue
95,119,036
84,251,450
12.9 %
13,092,696
12,205,990
7.3 %Other revenue
1,186,100
998,677
18.8 %
383,244
330,950
15.8 %Gross revenue
96,305,136
85,250,127
13.0 %
13,475,940
12,536,940
7.5 %Total deductions
86,379,229
76,305,839
13.2 %
6,050,440
5,663,850
6.8 %Net revenue 
$9,925,907
$8,944,288
11.0 %
$7,425,500
$6,873,090
8.0 %

























SAME FACILITY:


























ACUTE
BEHAVIORAL HEALTH

12/31/25
12/31/24
%  change
12/31/25
12/31/24
%  change












Hospitals owned and leased
28
28
0.0 %
334
334
0.0 %Average licensed beds
6,830
6,763
1.0 %
24,087
23,909
0.7 %Average available beds
6,658
6,591
1.0 %
23,987
23,809
0.7 %Patient days
1,621,440
1,621,966
0.0 %
6,415,058
6,344,903
1.1 %Average daily census
4,442.3
4,431.6
0.2 %
17,575.5
17,335.8
1.4 %Occupancy-licensed beds
65.0 %
65.5 %
-0.7 %
73.0 %
72.5 %
0.6 %Occupancy-available beds
66.7 %
67.2 %
-0.8 %
73.3 %
72.8 %
0.6 %Admissions
339,174
334,918
1.3 %
469,571
467,508
0.4 %Length of stay
4.8
4.8
0.0 %
13.7
13.6
0.7 %












Prior year amounts related to certain facilities previously included in our Behavioral Health Care Services' results have been reclassified into our Acute Care Hospital Services' results as of May 1, 2024 to conform with current year presentation. Universal Health Services, Inc.Supplemental Non-GAAP Disclosures2026 Operating Results Forecast(in thousands, except per share amounts)






















Forecast For The Year Ending December 31, 2026




% Net


% Net


Low
revenues
High
revenuesNet revenues

$18,417,000


$18,789,000











Adjusted net income attributable to UHS (a)
$1,366,561


$1,479,817











 Depreciation and amortization

671,628


671,628

 Interest expense

181,140


181,140

 Other (income) expense, net

(7,960)


(7,960)

 Provision for income taxes

429,183


464,751

Adjusted EBITDA net of NCI (b)

$2,640,552
14.3 %
$2,789,376
14.8 %









Adjusted net income attributable to UHS, per diluted share (a)$22.64


$24.52











Shares used in computing diluted earnings per share
60,349


60,349


(a) Adjusted net income attributable to UHS/per diluted share exclude the following items because we do not believe we can forecast these items with sufficient accuracy. Such items include: the impact of future items, if applicable, that are nonrecurring or non-operational in nature including items such as pre-tax unrealized gains/losses resulting from changes in the value of certain non-marketable securities, the impact of ASU 2016-09, and other potential material items including, but not limited to, impairments of goodwill, long-lived and intangible assets, reserves for various matters including settlements, legal judgments and lawsuits, costs related to extinguishment of debt, gains/losses on sales of assets and businesses, potential impacts of non-ordinary acquisitions, divestitures, joint ventures or other strategic transactions, other amounts that may be reflected in the current or prior year financial statements that relate to prior periods, and the impact of share repurchases that differ from our forecasted assumptions. Adjusted net income attributable to UHS/per diluted share is also subject to certain conditions including those as set forth in General Information, Forward-Looking Statements and Risk Factors and Non-GAAP Financial Measures.










(b) Adjusted EBITDA net of NCI is a non-GAAP financial measure and should not be considered a measure of financial performance under GAAP.  We believe Adjusted EBITDA net of NCI is helpful to our investors as a measure of operating performance. 



View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-financial-results-for-the-three-and-twelve-month-periods-ended-december-31-2025-and-operating-results-forecast-for-the-full-year-of-2026-302697559.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE-MONTH PERIODS ENDED DECEMBER 31, 2025 AND OPERATING RESULTS FORECAST FOR THE FULL YEAR OF 2026

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDENDFebruary 12, 2026 4:15 PM
PR Newswire (US)

KING OF PRUSSIA, Pa., Feb. 12, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on March 16, 2026 to shareholders of record as of  March 02, 2026.Universal Health Services, Inc. is one of the nation's largest providers of hospital and healthcare services.  Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.



View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-dividend-302686891.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALLFebruary 2, 2026 4:10 PM
PR Newswire (US)

KING OF PRUSSIA, Pa., Feb. 2, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its fourth quarter ended December 31, 2025, after the market closes on Wednesday, February 25, 2026. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Thursday, February 26, 2026.A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico. 



View original content:https://www.prnewswire.com/news-releases/universal-health-services-inc-announces-date-for-fourth-quarter-2025-earnings-release-and-conference-call-302673833.htmlSOURCE Universal Health Services, Inc.

Original: UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DATE FOR FOURTH QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

$UHS Major investigations are going on in Hospitals all around the country concerning this: “These families have shared accounts of treatment protocols that were forced upon victims with what they feel was improper informed consent, as well as the denial of access to alternative treatments that might have lessened suffering or prevented hospitalization. Due to unprecedented policy, the victims were isolated from their loved ones, and many were forced to die alone. Their concern is that these policies and practices may have violated both the rights and the well-being of Oklahomans during one of the most difficult times in our history…” WOW.

Oklahoma will be INVESTIGATING the Covid Dictators and Mass Murderers.

“These families have shared accounts of treatment protocols that were forced upon victims with what they feel was improper informed consent, as well as the denial of access to alternative treatments… pic.twitter.com/huCrfGWPOS— Liz Churchill (@liz_churchill10) December 5, 2025

UHS new 52 week high

Never in the History and we seen prices this low. I truly believe 100% we reached bottom this past week we had three extremely exciting days that we made up over 4000 points we still have a ways to go but it’s definitely going up. We are going to experience a huge bounce that we’ve never witnessed before in the ones that are in are going to experience life changes returns with in only a few weeks!!!!!! Look very close at all the call options that are very cheap. We could see a very exciting huge bounce that could push us over $165 with in only a few weeks from now!!!

Monday morning is the time to go all in..

Cheers everyone

Buy buy, today is the come back . The big V starts today this is when the huge Barnes returns back to 29,500 with in weeks?? Dont miss the boat!!

Cheers

Wow, this baby is the best & biggest time to buy buy!!!! You will make a life changes with baby going this low???? Turn 10k into 500k in a very very short time!!! Im all in now just put in 25k !!! With in only 4 weeks my 25k will be over $600k

Cheers everyone who buys this baby!!!

http://www.cnbc.com/2016/12/07/universal-health-services-stock-falls-nearly-12-after-buzzfeed-news-investigative-report.html?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104153166

http://ih.advfn.com/p.php?pid=nmona&article=73088360

https://www.buzzfeed.com/rosalindadams/intake?utm_term=.tfEyaJyYrA#.jdko7VoBL5

~ Monday! $UHS ~ Earnings posted, pending or coming soon! In Charts and Links Below!

~ $UHS ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.








http://stockcharts.com/h-sc/ui?s=UHS&p=D&b=3&g=0&id=p88783918276&a=237480049




http://stockcharts.com/h-sc/ui?s=UHS&p=W&b=3&g=0&id=p54550695994



~ Google Finance: http://www.google.com/finance?q=UHS
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=UHS#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=UHS+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=UHS
Finviz: http://finviz.com/quote.ashx?t=UHS
~ BusyStock: http://busystock.com/i.php?s=UHS&v=2


<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=UHS >>>>>>



http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916

*If the earnings date is in error please ignore error. I do my best.

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. As of February 28, 2011, the Company owned and/or operated 25 acute care hospitals and 206 behavioral health centers located in 37 states, Washington, Distrct of Columbia, Puerto Rico and the United States, Virgin Islands. The Company operates in three segments: acute care hospital services, behavioral health care services and others. The other segment includes centralized services, including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting. Services provided by its hospitals include general and specialty surgery, internal medicine, obstetrics, coronary care and pediatric services. In November, 2010, the Company completed the acquisition of Psychiatric Solutions, Inc. (PSI).

http://www.google.com/finance?q=UHS